Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04504682 · ClinicalTrials.gov registry record · NA
Ambulation With Labor Epidural in Obese Women
A NA study, sponsored by University of Chicago.
- Terminated
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT04504682: Clinical Trial NA study, sponsored by University of Chicago.
NCT04504682 is a NA study that was terminated before completion, run by University of Chicago. The registered enrollment target is 14 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04504682, a NA study, was terminated before completion, sponsored by University of Chicago.
- TERMINATED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if ambulation with a labor epidural in place is associated with decreased rate of cesarean delivery in obese patients.
Primary Outcome
Percent of cesarean delivery
Interventions
- BEHAVIORAL Ambulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2020-08-25 |
| Est. Completion | 2022-05-31 |
| Phase | NA |
Why NCT04504682 stopped before completion
NCT04504682 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Ambulation is the first listed.
NCT04504682 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04504682 about?
NCT04504682 is a clinical study titled "Ambulation With Labor Epidural in Obese Women". The purpose of this study is to determine if ambulation with a labor epidural in place is associated with decreased rate of cesarean delivery in obese patients.
What is the current status of trial NCT04504682?
This trial is currently terminated. It is a NA study. The enrollment target is 14 participants. The study started on 2020-08-25. Estimated completion is 2022-05-31.
What interventions are being tested in trial NCT04504682?
The interventions under investigation include: Ambulation (BEHAVIORAL).
Who is sponsoring clinical trial NCT04504682?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04504682's enrollment target sits among peer trials
14 1909th of 2000 higher than 90 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy